The Curious Case Of The Pandemic And AstraZeneca’s Pulmicort In China
Blockbuster Sales Recover As Life Returns To Normal
Executive Summary
China’s adherence to face masks to protect against COVID-19 has also helped children avoid other respiratory infections.
You may also be interested in...
Slow And Steady: Merck Advances COVID-19 Antiviral, Vaccine Programs
Merck’s third quarter beat analyst consensus and the company raised its guidance. The COVID-19-battered vaccines business began to improve but Gardasil’s recovery was slower than expected.
US Backs Oral COVID-19 Therapies And ‘Next Pandemic’ Drug Discovery With $3.2bn
Aiming to mimic public-private COVID-19 vaccine success, the US NIH will fund pandemic drug research, including taking candidates up to Phase II.
Can JAK Inhibitors Save Lives From COVID-19? Pfizer Might Let RECOVERY Answer The Question
Pfizer has unveiled promising results from a study of Xeljanz but needs a bigger trial. Given RECOVERY’s track record, the pharma company may opt to wait for its results.